Cystic angiomatosis is a rare bone condition with complex presentation and difficult treatment. Current management strategies have poorly tolerated side effects and a low likelihood of disease eradication. The control of calvarial lesions that are symptomatic usually involves surgical excision and subsequent cranioplasty. This paradigm can present with a risk of morbidity and mortality depending on the anatomy of the lesion. Here, the authors present a novel approach to a difficult-to-treat occipital calvarial lesion directly overlying the transverse sinus, performing a small, partial-thickness craniectomy and alcohol sclerotherapy in a combined neurosurgery-neuroendovascular approach. At 3 years after treatment, the authors noted a complete, encouraging radiographic and clinical outcome.

Download full-text PDF

Source
http://dx.doi.org/10.3171/2020.3.PEDS2045DOI Listing

Publication Analysis

Top Keywords

cystic angiomatosis
8
angiomatosis skull
4
skull lesion
4
lesion obliteration
4
obliteration neuroendovascular
4
neuroendovascular sclerotherapy
4
sclerotherapy unique
4
unique treatment
4
treatment case
4
case report
4

Similar Publications

Article Synopsis
  • Von Hippel-Lindau is a rare genetic disorder with an autosomal dominant inheritance pattern, leading to multiple vascular tumors, especially in the brain, eyes, and organs.
  • The disease can manifest at any age, with retinal tumors often being one of the first signs; MRI and fluorescein angiography are key diagnostic tools.
  • A case study highlights a woman in her late 30s with vision loss, revealing various eye and kidney abnormalities, including cystic lesions in her brain and elevated urine protein levels.
View Article and Find Full Text PDF

Background: To investigate the unique properties of clinical manifestation and radiological imaging for differential diagnosis of optic nerve hemangioblastoma (ONH) from adult optic nerve glioma (ONG) prior to surgical resection.

Methods: ONH and adult ONG patients were recruited from 2012 to 2022.

Results: A total of seven ONH patients (8 eyes) and 23 adult ONG patients (24 eyes) were assessed.

View Article and Find Full Text PDF
Article Synopsis
  • - The LITESPARK-004 study is testing the hypoxia-inducible factor-2α inhibitor, belzutifan, for its effectiveness in treating tumors associated with von Hippel-Lindau disease, specifically focusing on patients with central nervous system (CNS) haemangioblastomas after additional follow-up.
  • - A total of 61 patients, with a majority having CNS haemangioblastomas, were enrolled in this phase 2 study across multiple cancer centers in four countries, and they received oral belzutifan until there were unacceptable side effects or disease progression.
  • - The study assesses the antitumor activity by evaluating patient responses using two different methods based on tumor measurements and is ongoing, with results still being
View Article and Find Full Text PDF

Rationale: Hemangioblastomas occur both sporadically and as an important component of von Hippel-Lindau (VHL) disease. The typical MRI features of hemangioblastoma are cysts with enhanced cystic wall nodules in the cerebellum or lesions with uniform enhancement on the surface or inside the spinal cord. If there is edema around hemangioblastoma, it is easy to be misdiagnosed as brain metastasis on MRI.

View Article and Find Full Text PDF

Objective: To determine the reliability of an MRI-based qualitative kidney imaging surveillance scoring system (KISSS) and assess which imaging features predict growth rate (GR) of renal tumors in patients with VHL.

Materials And Methods: We identified 55 patients with VHL with 128 renal tumors who underwent intervention from 2015 to 2020 at the National Cancer Institute. All patients had 2 preoperative MRIs at least 3 months apart.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!